Newsfeed
Every published oncology item from an approved source, most recent first. No account required — this is the unfiltered stream, not personalized to any follows.
Items are tagged with the biomarkers and tumour types they resolve to; each tag opens that record, and every record’s page carries the same items back.
This demo serves a captured snapshot of the feed, not a live connection to the sources.
PubMed Central · Jun 18, 2026
Hematological Inflammation Markers in the Prediction of Clinically Significant Prostate Cancer and the Individualization of Biopsy Decisions for PI-RADS 3 Lesions: A Two-Center Retrospective Study.
Read at PubMed CentralPubMed Central · Jun 18, 2026
Catheter based intraperitoneal chemotherapy using taxane for peritoneal metastases from gastric cancer: from bench to bedside-a narrative review.
Read at PubMed CentralPubMed Central · Jun 17, 2026
Ketogenic Diet Alleviates Colorectal Cancer by Attenuating Macrophage M2 Polarisation Triggered by Oncometabolite MMA Derived From the Gut Microbiota.
Read at PubMed CentralPubMed Central · Jun 17, 2026
Standardized Analytical Verification of ctDNA ESR1 Mutation Testing in Metastatic HR+/HER2- Breast Cancer: A European Multicentre Study Using dPCR and NGS-Based Liquid Biopsy.
Read at PubMed CentralPubMed Central · Jun 16, 2026
Breast cancer incidence and mortality in population studies of radiation exposure: systematic review and meta-analysis.
Read at PubMed CentralPubMed Central · Jun 16, 2026
Diagnostic Performance of ⁶⁸Ga-FAPI PET/CT, ¹⁸F-FDG PET/CT, and Breast MRI for Assessing Tumor Extent and Axillary Metastasis in Breast Cancer: A Histopathology-Referenced Retrospective Study.
Read at PubMed CentralPubMed Central · Jun 16, 2026
Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After Curative-Intent Surgery: Local Therapies are Associated with Longer Survival in Selected Cases: A Systematic Review and Meta-analysis.
Read at PubMed CentralPubMed Central · Jun 16, 2026
Diagnostic performance of (18)F-FDG PET/CT in the prediction of axillary lymph node metastasis in Luminal A breast cancer.
Read at PubMed CentralPubMed Central · Jun 16, 2026
GWAS meta-analysis provides new insights into uveal melanoma risk.
Read at PubMed CentralPubMed Central · Jun 16, 2026
Implications of wait times for sentinel node biopsy on melanoma disease progression, micrometastatic tumour burden and survival outcomes in the modern treatment era.
Read at PubMed CentralPubMed Central · Jun 15, 2026
Distance to Care, Regional Context, and Survival in Early-Onset Colorectal Cancer.
Read at PubMed CentralPubMed Central · Jun 15, 2026
Cost-Effectiveness of Pelvic Floor Reconstruction Using Biological Mesh After Extralevator Abdominoperineal Resection for Rectal Cancer.
Read at PubMed CentralPubMed Central · Jun 14, 2026
Tumor Burden Modifies the Prognostic Impact of Adequate Lymph Node Dissection in Patients Undergoing Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.
Read at PubMed CentralPubMed Central · Jun 13, 2026
Oral vitamin B₁₂ after total gastrectomy for gastric cancer: mapping the evidence.
Read at PubMed CentralPubMed Central · Jun 13, 2026
Can ovarian cancer screening work? A secondary analysis of the UK collaborative trial of ovarian cancer screening.
Read at PubMed CentralPubMed Central · Jun 13, 2026
ADSC-Derived CCL8 Regulates HIF-1α Signaling and Promotes Colorectal Cancer Progression in a 3D Coculture Platform.
Read at PubMed CentralPubMed Central · Jun 12, 2026
Annual report of national clinical database-breast cancer registry in 2023: systemic therapy for small breast cancer.
Read at PubMed CentralPubMed Central · Jun 12, 2026
Membrane Fusion-Mediated Cytosolic Delivery of Threose Nucleic Acids via Homotypic Nanoparticles Overcomes Drug Resistance in Triple-Negative Breast Cancer.
Read at PubMed CentralPubMed Central · Jun 12, 2026
Prospective Trial on Tolerability and Efficacy of Adjuvant Nedaplatin Plus Docetaxel for Non-Small Cell Lung Cancer.
Read at PubMed CentralPubMed Central · Jun 12, 2026
Tumor cell-intrinsic NSUN2 deficiency reprograms macrophages to sensitize non-small cell lung cancer to EGFR inhibitors by reversing immune evasion.
Read at PubMed Central